Figure S1. Provides TIMM9 expression, from the oxidative phosphorylation pathway, in samples from the METABRIC study, classified by subtype and relapse-free survival curves according to TIMM9 expression for the luminal breast cancer subtypes. Here, TIMM9 is linked to breast cancer.